CYTOVAC A/S — Credit Rating and Financial Key Figures
Credit rating
Company information
About CYTOVAC A/S
CYTOVAC A/S (CVR number: 31262666) is a company from RUDERSDAL. The company recorded a gross profit of -9086 kDKK in 2016. The operating profit was -16.2 mDKK, while net earnings were -12.7 mDKK. The profitability of the company measured by Return on Assets (ROA) was -137.4 %, which can be considered poor and Return on Equity (ROE) was -136.7 %, which can be considered poor. The equity ratio, a key indicator for solidity, stood at 78.8 %, a level that can be considered to be good. This shows that a large part of the company's assets are funded by shareholders' equity, reducing financial risk. CYTOVAC A/S's liquidity measured by quick ratio was 4 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.
Financial information
See financialsGross profit (kDKK)
EBIT (kDKK)
Profitability
Solidity
Key figures (kDKK)
See financials2016 | |
---|---|
Volume | |
Net sales | |
Gross profit | -9 086.00 |
EBIT | -16 176.00 |
Net earnings | -12 683.00 |
Shareholders equity total | 9 275.00 |
Balance sheet total (assets) | 11 776.00 |
Net debt | -5 596.00 |
Profitability | |
EBIT-% | |
ROA | -137.4 % |
ROE | -136.7 % |
ROI | -173.7 % |
Economic value added (EVA) | -12 681.43 |
Solvency | |
Equity ratio | 78.8 % |
Gearing | 0.4 % |
Relative net indebtedness % | |
Liquidity | |
Quick ratio | 4.0 |
Current ratio | 4.0 |
Cash and cash equivalents | 5 634.00 |
Capital use efficiency | |
Trade debtors turnover (days) | |
Net working capital % | |
Credit risk | |
Credit rating | BBB |
Variable visualization
Roles
Companies in the same industry
- Professional credit risk reports
- Create your own estimates for any company
- Valuation analysis
- All 400,000+ Danish companies
- See instructions

... and more!
No registration needed.